Catechol-O-Methyltransferase Polymorphism Is Associated With Increased Uterine Leiomyoma Risk in Different Ethnic Groups
Authors:
- 1 February 2006
- journal article
- Published by Springer Nature in Journal of the Society for Gynecologic Investigation
- Vol. 13 (2) , 136-144
Abstract
Uterine leiomyomas (ULMs) are estrogen-dependent tumors that are more common in African American women. The etiology for such ethnic disparity is currently unknown. Catechol-O-methyltransferase (COMT) is an essential enzyme in estrogen metabolism. In the current study, we investigated the association of the functional COMT Val158Met polymorphism with ULM in different ethnic groups. We also studied the biologic role of COMT in tumor formation in human and rat leiomyoma cell lines and the potential therapeutic utility of COMT inhibitors. The genotype frequencies of the functional COMT Val158Met polymorphism among participants with (186 women) or without (142 women) ULMs were compared, as was the differential ethnic distribution of that polymorphism using polymerase chain reaction (PCR) and restriction-fragment linkage polymorphism. Proliferation, Western blot, and reporter transactivation analyses were applied to myometrial and leiomyoma cells representative of different COMT genotypes. Women with the high-activity COMT Val/Val genotype are 2.5 times more likely to develop ULMs than women with other genotypes (confidence interval, 1.017 to 6.151; P <.001). The prevalence of this genotype was significantly higher in African American women (47%) compared with white (19%) or Hispanic (30%) women (P = .003). Myometrial cell lines expressing the Val/Val genotype exhibited significantly enhanced responses to estrogen in proliferation and in estrogen-responsive element reporter assays. COMT-specific inhibitors reversed such a response and induced apoptosis. Myometrial specimens from Val/Val women demonstrated distinct estrogen-regulated gene expression that was consistent with enhanced proliferation and decreased apoptosis. The high-activity COMT Val/Val genotype is associated with increased risk of ULM. Our results provide a possible explanation for the higher prevalence of ULMs among African American women and offer a potential new target for nonsurgical treatment using COMT inhibitors.Keywords
This publication has 18 references indexed in Scilit:
- Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyomaFertility and Sterility, 2005
- Gene therapy of uterine leiomyomas: Adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude miceAmerican Journal of Obstetrics and Gynecology, 2004
- Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levelsJournal of the Society for Gynecologic Investigation, 2003
- Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomataHuman Reproduction, 2001
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Leiomyoma Primary Cultures Have Elevated Transcriptional Response to Estrogen Compared With Autologous Myometrial CulturesJournal of the Society for Gynecologic Investigation, 1995
- The Frequency of Uterine LeiomyomasAmerican Journal of Clinical Pathology, 1990
- The clinical significance of uterine leiomyomas in pregnancyAmerican Journal of Obstetrics and Gynecology, 1989
- Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiationMolecular and Cellular Endocrinology, 1989
- Synthesis of catechol estrogens by human uterus and leiomyomaSteroids, 1981